Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …

Background Trichotillomania (TTM) is a difficult‐to‐treat psychiatric condition with no first‐
line medications approved by the Food and Drug Administration. Individuals with TTM often …

Background Depression is usually managed in primary care, but most antidepressant trials
are of patients from secondary care mental health services, with eligibility criteria based on …

Background Depression and anxiety are the most frequent indication for which
antidepressants are prescribed. Long‐term antidepressant use is driving much of the …

Modern neuropsychopharmacology commenced in the 1950s with the serendipitous
discovery of first-generation antipsychotics and antidepressants which were therapeutically …

Current treatment for depression is not considered effective among all cases and, thus far,
nutritional protocols are minimal within depression treatment guidelines. Recently, there has …

Background Subclinical depression (SD) is a mental health disorder characterized by minor
depressive symptoms. Most SD patients are treated in the primary practice, but many …

ABSTRACT INTRODUCTION Evidence for the effectiveness of drug treatment for depression
in primary care settings remains limited, with little information on newer antidepressant …

Background Subthreshold depression (StD) is considered to be the “precursor” stage of
major depressive disorder (MDD), which could cause higher risk of suicide, disease burden …

Close connections between depression and type 2 diabetes (T2DM) have been suggested
by many epidemiological and experimental studies. Disturbances in insulin sensitivity due to …